Advances in additive manufacturing strategies for tailored drug release and tissue platforms

Additive manufacturing offers a versatile toolbox for engineering biomaterials with precise control over architecture, composition, and drug release dynamics. Among these techniques, extrusion-based 3D printing has been widely explored for its ability to customise biomaterials to mimic native tissues, fabricate patterned hydrogels, and enable hybrid printing with multifunctional capabilities-allowing spatiotemporal regulation of both tissue engineering platforms and drug delivery systems. These approaches not only support targeted drug delivery but also advance implantable scaffolds for in situ therapeutic release. In this talk, we will discuss recent advances in additive manufacturing strategies for tailoring drug release kinetics and highlight how the convergence of these technologies is paving the way toward hybrid platforms that can both engineer functional tissues and deliver therapeutics with the precision required for personalised medicine.